Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Huang, Li Feng ^a   Yao, Yong Ming ^a   Li, Jin Feng ^b   Dong, Ning ^a   Liu, Chen ^c   Yu, Yan ^a   He, Li Xin ^a   Sheng, Zhi Yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GELSOLIN; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ARTICLE; BLOOD SAMPLING; BURN PATIENT; CAUSAL ATTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; FATALITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE; BLOOD; BURN; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MORTALITY;

ADULT; BURNS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GELSOLIN; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MULTIPLE ORGAN FAILURE; PROGNOSIS; SURVIVAL RATE; T-LYMPHOCYTES;

EID: 80055105130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025748     Document Type: Article

References (46)

1. Accardo-Palumbo A, D'Amelio L, Pileri D, D'Arpa N, Mogavero R, et al. (2010) Reduction of plasma granzyme acorrelates with severity of sepsis in burn patients. Burns 36: 811-818.
2. Venet F, Tissot S, Debard AL, Faudot C, Crampé C, et al. (2007) Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med 35: 1910-1917.
3. Martin AC, Kaschube M, Wieschaus EF, (2009) Pulsed contractions of an actin-myosin network drive apical constriction. Nature 457: 495-499.
4. Haddad JG, Harper KD, Guoth M, Pietra GG, Sanger JW, (1990) Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci USA 87: 1381-1385.
5. Erukhimov JA, Tang ZL, Johnson BA, Donahoe MP, Razzack JA, et al. (2000) Actin-containing sera from patients with adult respiratory distress syndrome are toxic to sheep pulmonary endothelial cells. Am J Respir Crit Care Med 16: 288-294.
6. Hemric ME, Tracy PB, Haeberle JR, (1994) Caldesmon enhances the binding of myosin to the cytoskeleton during platelet activation. J Biol Chem 269: 4125-4128.
7. Pottiez G, Haverland N, Ciborowski P, (2010) Mass spectrometric characterization of gelsolin isoforms. Rapid Commun Mass Spectrom 24: 2620-2624.
8. Ferjani I, Fattoum A, Bettache N, Seantier B, Milhiet PE, et al. (2010) The gelsolin:calponin complex nucleates actin filaments with distinct morphologies. Biochem Biophys Res Commun 392: 118-123.
9. Nag S, Ma Q, Wang H, Chumnarnsilpa S, Lee WL, et al. (2009) Ca2+ binding by domain plays a critical role in the activation and stabilization of gelsolin. Proc Natl Acad Sci USA 106: 13713-13718.
10. Bucki R, Levental I, Kulakowska A, Janmey PA, (2008) Plasma gelsolin: function, prognostic value, and potential therapeutic use. Curr Protein Pept Sci 9: 541-551.
11. Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, et al. (2008) Plasma gelsolin depletion and circulating actin in sepsis: a pilot study. PLoS One 3: e3712.
12. Lind SE, Smith DB, Janmey PA, Stossel TP, (1986) Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation. J Clin Invest 78: 736-742.
13. Rothenbach PA, Dahl B, Schwartz JJ, O'Keefe GE, Yamamoto M, et al. (2004) Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 96: 25-31.
14. Christofidou-Solomidou M, Scherpereel A, Solomides CC, Muzykantov VR, Machtay M, et al. (2002) Changes in plasma gelsolin concentration during acute oxidant lung injury in mice. Lung 180: 91-104.
15. Becker PM, Kazi AA, Wadgaonkar R, Pearse DB, Kwiatkowski D, et al. (2003) Pulmonary vascular permeability and ischemic injury in gelsolin-deficient mice. Am J Respir Cell Mol Biol 28: 478-484.
16. Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, et al. (2007) Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 35: 849-855.
17. DiNubile MJ, Stossel TP, Ljunghusen OC, Ferrara JL, Antin JH, (2002) Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation. Blood 100: 4367-4371.
18. Lee PS, Drager LR, Stossel TP, Moore FD, Rogers SO, (2006) Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg 243: 399-403.
19. Mounzer KC, Moncure M, Smith YR, Dinubile MJ, (1999) Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med 160: 1673-1681.
20. Osborn TM, Dahlgren C, Hartwig JH, Stossel TP, (2007) Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 292: C1323-1330.
21. Suhler E, Lin W, Yin HL, Lee WM, (1997) Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med 25: 594-598.
22. Lavrentieva A, Kontakiotis T, Bitzani M, Papaioannou-Gaki G, Parlapani A, et al. (2008) Early coagulation disorders after severe burn injury: impact on mortality. Intensive Care Med 34: 700-706.
23. Nguyen LN, Nguyen TG, (2009) Characteristics and outcomes of multiple organ dysfunction syndrome among severe-burn patients. Burns 35: 937-941.
24. Schwacha MG, Schneider CP, Chaudry IH, (2002) Differential expression and tissue compartmentalization of the inflammatory response following thermal injury. Cytokine 17: 266-274.
25. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL, (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286: 1754-1758.
26. Greenhalgh DG, Saffle JR, Holmes JH 4th, Gamelli RL, Palmieri TL, et al. (2007) American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 28: 776-790.
27. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.
28. Davis TA, Stojadinovic A, Anam K, Amare M, Naik S, et al. (2009) Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury. Int Wound J 6: 11-21.
29. Park JO, Shin SD, Kim J, Song KJ, Peck MD, (2009) Association between socioeconomic status and burn injury severity. Burns 35: 482-490.
30. Lee WM, Galbraith RM, (1992) The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326: 1335-1341.
31. DiNubile MJ, (2008) Plasma gelsolin as a biomarker of inflammation. Arthritis Res Ther 10: 124.
32. Lee PS, Bhan I, Thadhani R, (2010) The potential role of plasma gelsolin in dialysis-related protein-energy wasting. Blood Purif 29: 99-101.
33. Spinardi L, Witke W, (2007) Gelsolin and diseases. Subcell Biochem 45: 55-69.
34. Lind SE, Smith DB, Janmey PA, Stossel TP, (1988) Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury. Am Rev Respir Dis 138: 429-434.
35. Rosengart MR, Arbabi S, Bauer GJ, Garcia I, Jelacic S, et al. (2002) The actin cytoskeleton: an essential component for enhanced TNFalpha production by adherent monocytes. Shock 17: 109-113.
36. Huang S, Rhoads SL, DiNubile MJ, (1997) Temporal association between serum gelsolin levels and clinical events in a patient with severe falciparum malaria. Clin Infect Dis 24: 951-954.
37. Bucki R, Georges PC, Espinassous Q, Funaki M, Pastore JJ, et al. (2005) Inactivation of endotoxin by human plasma gelsolin. Biochemistry 44: 9590-9597.
38. Goetzl EJ, Lee H, Azuma T, Stossel TP, Turck CW, et al. (2000) Gelsolin binding and cellular presentation of lysophosphatidic acid. J Bio Chem 275: 14573-14578.
39. Rothenbach PA, Dahl B, Schwartz JJ, O'Keefe GE, Yamamoto M, et al. (2004) Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physio 96: 25-31.
40. Demling RH, Kramer G, Harms B, (1984) Role of thermal injury-induced hypoproteinemia on fluid flux and protein permeability in burned and nonburned tissue. Surgery 95: 136-144.
41. Fang CH, James HJ, Ogle C, Fischer JE, Hasselgren PO, (1995) Influence of burn injury on protein metabolism in different types of skeletal muscle and the role of glucocorticoids. J Am Coll Surg 180: 33-42.
42. Wang HH, Cheng BL, Chen QX, Wu SJ, Lv C, et al. (2008) Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care 12: R106.
43. Huang LF, Yao YM, Dong N, Yu Y, He LX, et al. (2010) Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study. Crit Care 14: R3.
44. Huang LF, Yao YM, Zhang LT, Dong N, Yu Y, et al. (2009) The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. Shock 31: 322-329.
45. Yao YM, Sheng ZY, Huang LF, (2009) The effect of a novel cytokine, high mobility group box 1 protein, on the development of traumatic sepsis. Chin J Integr Med 15: 13-15.
46. Zhang LT, Yao YM, Yao FH, Huang LF, Dong N, et al. (2010) Association between high-mobility group box-1 protein release and immune function of dendritic cells in thermal injury. J Interferon Cytokine Res 30: 487-495.